NCI Drug Development Workshop (Materials)

Materials

The recording of each session will be posted within a week of its completion.

The Developmental Therapeutics Program (DTP) offers drug discovery and development resources and services to the research community. Visit https://dtp.cancer.gov/ for more information.

The Division of Cancer Treatment and Diagnosis (DCTD) is seeking project proposals for viral vector and cell therapy production at NCI.

The recordings are archived for future access at NCI Drug Development Workshop: | News & Events | DCTD (cancer.gov).

Session I - July 23, 2021
Recording link:	https://nci.rev.vbrick.com/#/videos/117154fc-1fac-46eb-bf35-3f4ea692111b
Presentation:	NCI Workshop Session I Grand Overview Key milestones in drug development and components of an IND-package
Session II - July 30, 2021
Recording link:	https://nci.rev.vbrick.com/sharevideo/52da8ce9-9635-4f2b-907f-e230cea5eeb4
Presentation:	Pre-clinical Proof of Concept: Establishing Activity, Bioavailability, and Associated Effect, in Cancer Relevant Models Preclinical pharmacology in IND-enabling studies and clinical pharmacology in clinical protocol development
Session III - August 6, 2021
Recording link:	https://nci.rev.vbrick.com/sharevideo/040958fd-d596-460f-af17-14719fa2eee2
Presentation:	Preliminary and IND-directed toxicology studies Assays and endpoints for toxicology studies to assess immune-related adverse events
Session IV - August 20, 2021
Recording link:	https://nci.rev.vbrick.com/sharevideo/1980c808-bd8a-44c9-96b2-863021095e98
Presentation:	Assays and Analytical Methods Needed for API Release Challenges in Early Phase API Scale Up The Role of Occam's Razor in Formulation Design
Session V - September 10, 2021
Recording link:	https://nci.rev.vbrick.com/sharevideo/33cf956b-b1fb-4e8c-8ae8-0f89f6a71224
Presentation:	Overview of Biologic Types and Various Applications in Cancer PROCESS DEVELOPMENT: Navigating the UP/DOWNstreams Characterization and Quality Control of Biological Products Cell Therapy: CMC considerations to prepare a bridge from preclinical to clinical
Session VI - September 24, 2021
Recording link:	https://nci.rev.vbrick.com/sharevideo/0cdb3459-8004-4740-9fb3-ab39b33410ba
Session VII - October 29, 2021
Recording link:	https://nci.rev.vbrick.com/sharevideo/7f8c8fea-30dd-42e7-a69c-c9619f8b351a
Presentation:	Clinical development of immunotherapies Building Effective Biomarker Plans: The Questions to Ask BEFORE You Write Your Letter of Intent Phase I trial design considerations and CTEP clinical trial resources
Session VIII - November 19, 2021
Recording link:	https://nci.rev.vbrick.com/#/videos/336b47f7-e2f2-44e2-b1ec-48364562c5fd
Presentation:	Creating a data package for biopharm/biotech Engaging with development partners
Session IX - December 3, 2021
Recording link:	https://nci.rev.vbrick.com/sharevideo/adbdf9b2-4205-4ece-98a4-214ec90aff46
Presentation:	NCI SBIR Funding for Drug Development NCI DTP Resources andthe Stepping StonesProgram NCI Experimental Therapeutics Program (NExT):A Government, Academic, Industry Partnership for Cancer Drug Discovery NExTCollaborations: How to Partner with NCI NCI DIVISION OF CANCER TREATMENT AND DIAGNOSIS (DCTD) FUNDING OPPORTUNITIES FOR EARLY PHASE THERAPEUTIC CLINICAL TRIALS The National Cancer Institute’s Patient-Derived Models Repository (PDMR)
Session X - December 10, 2021
Recording link:	https://nci.rev.vbrick.com/sharevideo/196f018b-fc67-40d5-ade0-91dbffc9654d?startAt=00m00s